2021
Chances and challenges of registry-based pharmacovigilance in multiple sclerosis: lessons learnt from the implementation of the multicenter REGIMS registry.
Simbrich, A., Thibaut, J., Khil, L., Maximov, S., Wiendl, H. and Berger, K.
Drug Safety 44
(1): 7-15.
January 2021
This list was generated on Sat Dec 21 18:05:31 2024 UTC.